These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31672029)

  • 1. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
    Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
    Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
    [No Abstract]   [Full Text] [Related]  

  • 2. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
    Ryoo IG; Lee SH; Kwak MK
    Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
    Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
    Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
    Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
    Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway.
    Tsai KJ; Tsai HY; Tsai CC; Chen TY; Hsieh TH; Chen CL; Mbuyisa L; Huang YB; Lin MW
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance.
    Kahroba H; Shirmohamadi M; Hejazi MS; Samadi N
    Life Sci; 2019 Dec; 239():116986. PubMed ID: 31678283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
    Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
    Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
    Ryoo IG; Choi BH; Ku SK; Kwak MK
    Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
    Wu T; Harder BG; Wong PK; Lang JE; Zhang DD
    Mol Carcinog; 2015 Nov; 54(11):1494-502. PubMed ID: 25154499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.
    Smit L; Berns K; Spence K; Ryder WD; Zeps N; Madiredjo M; Beijersbergen R; Bernards R; Clarke RB
    Oncotarget; 2016 Jan; 7(3):2596-610. PubMed ID: 26595803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of heme oxygenase-1 and its reaction product, carbon monoxide, in manifestation of breast cancer stem cell-like properties: Notch-1 as a putative target.
    Kim DH; Yoon HJ; Cha YN; Surh YJ
    Free Radic Res; 2018 Dec; 52(11-12):1336-1347. PubMed ID: 30238818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of versican in modulating breast cancer cell self-renewal.
    Du WW; Fang L; Yang X; Sheng W; Yang BL; Seth A; Zhang Y; Yang BB; Yee AJ
    Mol Cancer Res; 2013 May; 11(5):443-55. PubMed ID: 23449934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells.
    Ryoo IG; Choi BH; Kwak MK
    Oncotarget; 2015 Apr; 6(10):8167-84. PubMed ID: 25717032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.